Single Trial Success Stories: UCB’s Kygevvi Joins US FDA Approvals With Confirmatory Evidence

 
• By Bridget Silverman
  
Recent rare disease approvals show the US FDA is still willing to accept a range of confirmatory evidence when randomized controlled trials are not feasible (Shutterstock)

More from Rare Diseases

More from Real-World Evidence